Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2013 1
2016 1
2018 2
2019 2
2020 1
2021 3
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Hyperferritinemia-A Clinical Overview.
Sandnes M, Ulvik RJ, Vorland M, Reikvam H. Sandnes M, et al. Among authors: vorland m. J Clin Med. 2021 May 7;10(9):2008. doi: 10.3390/jcm10092008. J Clin Med. 2021. PMID: 34067164 Free PMC article. Review.
Myeloproliferative neoplasms and JAK2 mutations.
Almedal H, Vorland M, Aarsand AK, Grønningsæter IS, Bruserud Ø, Reikvam H. Almedal H, et al. Among authors: vorland m. Tidsskr Nor Laegeforen. 2016 Dec 6;136(22):1889-1894. doi: 10.4045/tidsskr.16.0128. eCollection 2016 Dec. Tidsskr Nor Laegeforen. 2016. PMID: 27929554 Free article. English, Norwegian.
A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria.
Bustad HJ, Toska K, Schmitt C, Vorland M, Skjærven L, Kallio JP, Simonin S, Letteron P, Underhaug J, Sandberg S, Martinez A. Bustad HJ, et al. Among authors: vorland m. Mol Ther. 2020 Feb 5;28(2):677-689. doi: 10.1016/j.ymthe.2019.11.010. Epub 2019 Dec 4. Mol Ther. 2020. PMID: 31810863 Free PMC article.
International external quality assurance of JAK2 V617F quantification.
Asp J, Skov V, Bellosillo B, Kristensen T, Lippert E, Dicker F, Schwarz J, Wojtaszewska M, Palmqvist L, Akiki S, Aggerholm A, Tolstrup Andersen M, Girodon F, Kjær L, Oppliger Leibundgut E, Pancrazzi A, Vorland M, Andrikovics H, Kralovics R, Cassinat B, Coucelo M, Eftimov A, Haslam K, Kusec R, Link-Lenczowska D, Lodé L, Matiakowska K, Naguib D, Navaglia F, Novotny GW, Percy MJ, Sudarikov A, Hermouet S, Pallisgaard N. Asp J, et al. Among authors: vorland m. Ann Hematol. 2019 May;98(5):1111-1118. doi: 10.1007/s00277-018-3570-8. Epub 2018 Dec 8. Ann Hematol. 2019. PMID: 30535576 Free PMC article. Clinical Trial.
Philadelphia chromosome positive AML arising from JAK2-positive myelofibrosis.
Brattås MK, Lilleeng K, Hovland R, Lægreid IJ, Vorland M, Leh F, Bruserud Ø, Gjertsen BT, Reikvam H. Brattås MK, et al. Among authors: vorland m. Biomark Res. 2018 Nov 21;6:33. doi: 10.1186/s40364-018-0147-6. eCollection 2018. Biomark Res. 2018. PMID: 30479769 Free PMC article.